DUBLIN--(BUSINESS WIRE)--The "Synthetic Biology - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.
Genome Engineering represents the single largest technology in the global market for Synthetic Biology, demand for which is estimated at US$2.9 billion (45% share) in 2017 and is projected to reach US$9.4 billion by 2023. During period 2017-2023, the market for Biological Components and Integrated Systems is slated to record the fastest CAGR of 24.8%.
The major factors propelling growth of Synthetic Biology market include declining prices of DNA sequencing and synthesis, materialization of innovative technologies, increased funding from government and private bodies, growing demand for better-quality drugs and vaccines and advancements in the area of molecular biology, to name a few.
However, the factors responsible for hampering growth of Synthetic Biology include expensive research protocols, biological safety, bio security concerns, ethical issues and cuts in reimbursement leading to pricing pressure.
Research Findings & Coverage:
- Synthetic Biology global market analyzed in this report with respect to synthetic biology prominent technologies, key products and major applications
- The report exclusively analyzes each product type, technology and applications of synthetic biology by major geographic region
- Synthetic Biology Aids in Creating Therapeutic Bacteria
- Application of Synthetic Biology to Generate Superior Biofactories
- Residual Synthetic Microbes to Formulate Fertilizer
- Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
- Major companies profiled - 36
- The industry guide includes the contact details for 233 companies
Product Outline:
The report analyzes the market for the technologies of Synthetic Biology including:
- Genome Engineering
- DNA Sequencing
- Biological Components and Integrated Systems
- Others
The study explores the market for product types of Synthetic Biology comprise the following:
- Oligonucleotides
- Enzymes
- Chassis Organism
- Others
Applications of Synthetic Biology studied in the report include the following:
- Medical
- Industrial
- Environmental
- Others
Analysis Period, Units and Growth Rates:
The report reviews, analyzes and projects the global Synthetic Biology market for the period 2014-2023 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2017 through 2023
Key Topics Covered:
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
1.1 Product Outline
1.1.1 Synthetic Biology - Objectives
1.1.2 Dissimilarities between the Synthetic Biology and System Biology
1.1.3 Synthetic Biology - An Evolution
1.1.4 Dissimilarities between Synthetic Biology and Genetic Engineering
1.1.5 Synthetic Biology Product Types
1.1.6 Technologies of Synthetic Biology
1.1.7 Synthetic Biology Applications
2. KEY MARKET TRENDS
2.1 Synthetic Biology Aids in Creating Therapeutic Bacteria
2.2 Development of Advanced Generation of Anti-venoms using Synthetic Bacteria
2.3 Application of Synthetic Biology to Generate Superior Biofactories
2.4 Synthetic Microbes for Fashion Purpose
2.5 Residual Synthetic Microbes to Formulate Fertilizer
3. KEY GLOBAL PLAYERS
- Amyris, Inc. (United States)
- ATUM (United States)
- Codexis, Inc. (Untied States)
- DSM Sinochem Pharmaceuticals (Singapore)
- E. I. du Pont de Nemours and Company (DuPont) (United States)
- Evolva SA (Switzerland)
- GENEWIZ, Inc (United States)
- Genscript Corporation (United States)
- Green Biologics Ltd. (The United Kingdom)
- Integrated DNA Technologies, Inc. (United States)
- Intrexon Corporation (United States)
- LC Sciences LLC (United States)
- Novozymes (Denmark)
- Qteros (United States)
- Renewable Energy Group, Inc. (United States)
- Millipore Sigma (Untied States)
- Synthetic Biologics, Inc. (United States)
- Synthetic Genomics (United States)
- Thermo Fisher Scientific, Inc. (United States)
4. KEY BUSINESS TRENDS
5. GLOBAL MARKET OVERVIEW
5.1 Global Synthetic Biology Market Overview by Product Type
5.2 Global Synthetic Biology Market Overview by Technology
5.3 Global Synthetic Biology Market Overview by Application
PART B: REGIONAL MARKET PERSPECTIVE
REGIONAL MARKET OVERVIEW
1. NORTH AMERICA
2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD
PART C: GUIDE TO THE INDUSTRY
1. NORTH AMERICA
2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
Companies Mentioned
- Amyris, Inc.
- ATUM
- Codexis, Inc.
- DSM Sinochem Pharmaceuticals
- E. I. du Pont de Nemours and Company (DuPont)
- Evolva SA
- GENEWIZ, Inc
- Genscript Corporation
- Green Biologics Ltd.
- Integrated DNA Technologies, Inc.
- Intrexon Corporation
- LC Sciences LLC
- Millipore Sigma
- Novozymes
- Qteros
- Renewable Energy Group, Inc.
- Synthetic Biologics, Inc.
- Synthetic Genomics
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/hsjlgt/synthetic_biology?w=4
